Am J Gastroenterol

1. WEGERMANN K, Smith AR, Dasarathy S, Welch N, et al
   Baseline characteristics of a prospective, multi-center study on the natural history of compensated cirrhosis: the Liver Cirrhosis Network.
   Am J Gastroenterol. 2026 Sep 18. doi: 10.14309/ajg.0000000000004211.
   

   >> Share

   
   
2. DEMIRTAS CO, Mezzacappa C, Sartoris R, Rautou PE, et al
   Noninvasive Prediction of Clinically Significant Portal Hypertension in Hepatocellular Carcinoma: A Tumor-Adjusted Model.
   Am J Gastroenterol. 2026 Sep 17. doi: 10.14309/ajg.0000000000004204.
   

   >> Share

   
   

   
   BMC Gastroenterol

3. ZHOU X, Wu X, Jin L, Zhao X, et al
   Development and validation of a risk model for non-fatty chronic liver disease in middle-aged and older adults with metabolic syndrome.
   BMC Gastroenterol. 2026;26:562.
   

   >> Share

   
   
4. WANG YC, Wong YJ, Jackson E, Dennis A, et al
   Characterisation of liver disease using quantitative MRI: report of the imaging arm of the ELEGANCE study.
   BMC Gastroenterol. 2026;26:576.
   

   >> Share

   
   
5. ROHANI FS, Emrani AS, Sasanfar B, Toorang F, et al
   Dietary total antioxidant capacity and its dietary sources in association with non-alcoholic fatty liver disease: a case-control study.
   BMC Gastroenterol. 2026;26:566.
   

   >> Share

   
   
6. ASHRAF H, Asif T, Baqir F, Naz N, et al
   Bioactive folate attenuates valproic acid-induced NAFLD in female rats.
   BMC Gastroenterol. 2026;26:574.
   

   >> Share

   
   
7. PATANKAR SF, Ramdass PVAK
   Non-HDL-to-HDL-cholesterol ratio and metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.
   BMC Gastroenterol. 2026;26:573.
   

   >> Share

   
   
8. LI GW, Li J, Kang Q, Yang C, et al
   Comparative effectiveness and safety of robotic versus laparoscopic liver resection for benign liver diseases: a systematic review and meta-analysis.
   BMC Gastroenterol. 2026;26:560.
   

   >> Share

   
   

   
   Cancer Res

9. ZHANG L, Zheng X, Fu H, Liu L, et al
   Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity.
   Cancer Res. 2026;86:4551-4568.
   

   >> Share

   
   

   
   Dig Dis Sci

10. ARORA U, Khare S, Anikhindi S, Khandelwal A, et al
    EUS-Guided Shear Wave Elastography in a Real-World Cohort: Diagnostic Accuracy and the Impact of Measurement Variability.
    Dig Dis Sci. 2026;71:5745-5753.
    

    >> Share

    
    
11. ATTANASI ML, Gregoski MJ, Rockey DC
    MELD and the Risk of Mortality Between Black and White Patients with Advanced Fibrosis.
    Dig Dis Sci. 2026;71:5729-5736.
    

    >> Share

    
    
12. GREB AC, Kim S, Roney A, Ting PS, et al
    Prevalence and Impact of Protein-Calorie Malnutrition in Hospitalized Patients with Steatotic Liver Disease.
    Dig Dis Sci. 2026;71:5378-5387.
    

    >> Share

    
    
13. ABUELAZM M, Hawas Y, Hamed BM, Awad A, et al
    The Efficacy and Safety of Clip-Assisted Endoscopic Cyanoacrylate Injection for Gastric Varices: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2026;71:5326-5345.
    

    >> Share

    
    

    
    Eur J Pediatr

14. LIN H, Peng XR, Qin XM, Zhang HM, et al
    Genetic and clinical spectrum of progressive familial intrahepatic cholestasis type 1: novel ATP8B1 variants and genotype-phenotype correlations.
    Eur J Pediatr. 2026;185:763.
    

    >> Share

    
    

    
    Eur Radiol

15. OCAL E, Ocal O, Corradini S, Umutlu M, et al
    Histopathological outcomes of CT-guided high-dose-rate interstitial brachytherapy for HCC and predictive accuracy of the LI-RADS Radiation Treatment Response Algorithm v2024.
    Eur Radiol. 2026;36:7659-7670.
    

    >> Share

    
    
16. QIU L, Xue L, Feng H, Meng F, et al
    Noninvasive prediction of severe histopathology in drug-induced liver injury using a dual elastography-based machine learning model.
    Eur Radiol. 2026;36:7609-7620.
    

    >> Share

    
    
17. ABBAS M, Andrade-Miranda G, Bourbonne V, Jaouen V, et al
    AI-driven volumetric approach for automatic chemotherapy response assessment in colorectal liver metastases.
    Eur Radiol. 2026;36:7490-7501.
    

    >> Share

    
    
18. YANG L, Wu F, Wang W, Rao S, et al
    Preoperative Gd-EOB-DTPA-enhanced MRI may help predict macrotrabecular-massive subtype and postoperative recurrence in small hepatocellular carcinoma (
    Eur Radiol. 2026 Sep 14. doi: 10.1007/s00330-026-12872.
    

    >> Share

    
    

    
    Gastroenterology

19. BELZ L, van den Heuvel D, Kilani B, Martinez-Navarro A, et al
    Neutrophil-Driven Trogocytosis in Pancreatic Ductal Adenocarcinoma Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression.
    Gastroenterology. 2026 May 6:S0016-5085(26)06818.
    

    >> Share

    
    

    
    Gastrointest Endosc

20. MATHEW A
    Cirrhosis and achalasia: How bold can we be?
    Gastrointest Endosc. 2026;104:664-665.
    

    >> Share

    
    
21. YAO P, Chen Y
    Interpreting histologic end points after endoscopic gastric remodeling for metabolic dysfunction-associated steatohepatitis.
    Gastrointest Endosc. 2026;104:694-695.
    

    >> Share

    
    
22. SAEED A, Akbar H, Xiao Y, Kumar A, et al
    Risk Factors for Bleeding Following Endoscopic Retrograde Cholangiopancreatography: A Systematic Review and Meta-analysis.
    Gastrointest Endosc. 2026 May 6:S0016-5107(26)06725.
    

    >> Share

    
    

    
    Hepatology

23. MATUTE-GONZALEZ M, Ronot M, Chernyak V, Sangro B, et al
    Response evaluation to systemic therapy in HCC: Current challenges and future perspectives.
    Hepatology. 2026;84:1025-1048.
    

    >> Share

    
    
24. SAMALA N, Cree MG, Bril F, Azziz R, et al
    Polyendocrine metabolic ovarian syndrome (PMOS): The impact of terminology update through the lens of gastroenterology & hepatology.
    Hepatology. 2026 Sep 14. doi: 10.1097/HEP.0000000000001855.
    

    >> Share

    
    
25. ZHANG C, Dunn N, Xie Y, Davidson NO, et al
    VPS13D protects against alcohol- associated steatohepatitis by regulating organelle contacts and VLDL secretion.
    Hepatology. 2026 Sep 14. doi: 10.1097/HEP.0000000000001847.
    

    >> Share

    
    
26. RONOT M, Calderaro J
    Incorporating artificial intelligence into imaging for surveillance and diagnosis of liver cancer: Innovations, challenges, and clinical translation.
    Hepatology. 2026;84:1121-1132.
    

    >> Share

    
    
27. WASSMER CH, Gelli M, Wong TCL, Li Z, et al
    The rise of transplant oncology in primary liver cancer and metastatic disease.
    Hepatology. 2026;84:1181-1208.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

28. WU Y
    Comment on "AKR1B10 Drives Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing Ferroptosis via NQO1/GPX4 Axis".
    J Gastroenterol Hepatol. 2026 Sep 15. doi: 10.1111/jgh.70748.
    

    >> Share

    
    

    
    J Hepatol

29. KHAN SA, Vithayathil M, Yip TCF, El-Serag HB, et al
    The changing epidemiology of primary liver cancer in the 21(st) century.
    J Hepatol. 2026;85:656-668.
    

    >> Share

    
    
30. SINGAL AG, Saborowski A, Parikh ND, Banales JM, et al
    The future of blood-based biomarkers in liver cancer.
    J Hepatol. 2026;85:683-694.
    

    >> Share

    
    
31. SAPISOCHIN G, O'Kane GM, Zorigtbaatar A, Yan Chan AC, et al
    Pushing the boundaries of liver resection for liver cancer.
    J Hepatol. 2026;85:740-752.
    

    >> Share

    
    
32. YIP TC, Innes H, Wong GL, Jepsen P, et al
    Surveillance of patients at risk of liver cancer: Expert opinions.
    J Hepatol. 2026;85:669-682.
    

    >> Share

    
    
33. YANG M, Wu X, Hu J, Wang Y, et al
    Corrigendum to: "COMMD10 inhibits HIF1alpha/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma" [J Hepatol (2022) 76(5):1138-1150; 10.1016/j.jhep.2022.01.009).
    J Hepatol. 2026 Sep 17:S0168-8278(26)02883-7. doi: 10.1016/j.jhep.2026.
    

    >> Share

    
    
34. MATUSCHEWSKI NJ, Baker W, Chapiro J, Calderaro J, et al
    Artificial intelligence and personalised medicine in liver cancer.
    J Hepatol. 2026;85:712-726.
    

    >> Share

    
    
35. JOO I, Lee JM, Ronot M
    Advances in the imaging of liver cancer.
    J Hepatol. 2026;85:695-711.
    

    >> Share

    
    
36. MAZZAFERRO V, Pinter M, Pillai A, Sposito C, et al
    Liver transplantation for primary liver cancers in the era of transplant oncology.
    J Hepatol. 2026;85:727-739.
    

    >> Share

    
    
37. EDELINE J, Kuang M, Reig M, Vilgrain V, et al
    Integrating systemic therapy in the earlier stages of liver cancer.
    J Hepatol. 2026;85:770-780.
    

    >> Share

    
    
38. VOGEL A, Kelley RK
    Systemic therapy for HCC: Doublets, triplets and beyond.
    J Hepatol. 2026;85:781-793.
    

    >> Share

    
    

    
    PLoS One

39. SHENG L, Zhang X, Weng H, Deng Q, et al
    Clinical efficacy of empiric antibiotic therapy in Chinese patients with cirrhosis and bacterial infections: A multicenter study.
    PLoS One. 2026;21:e0357491.
    

    >> Share

    
    
40. BOMMINENI V, Edison LK, Gottapu C, Butcher GD, et al
    Hepatic transcriptomic landscape of chicken reveals host responses to spotty liver disease.
    PLoS One. 2026;21:e0346466.
    

    >> Share

    
    
41. GALLEGO JJ, Casanova-Ferrer F, Fiorillo A, Lopez-Gramaje A, et al
    Eye movement analysis detects early neurological alterations in cirrhotic patients classified as not having minimal hepatic encephalopathy by the Psychometric Hepatic Encephalopathy Score.
    PLoS One. 2026;21:e0358353.
    

    >> Share

    
    
42. WALLACE C, Alessy SA, Abaalkhail F, Alghamdi S, et al
    Modelling the impact of physical activity on MASLD in Saudi Arabia.
    PLoS One. 2026;21:e0354332.
    

    >> Share

    
    
43. CISLARU A, Yagmur E, Bannon C, Cremen S, et al
    Dysregulation of the serum and IgG N-glycome in decompensated cirrhosis and its association with Model for End-Stage Liver Disease-Sodium (MELD-Na).
    PLoS One. 2026;21:e0357709.
    

    >> Share

    
    
44. HE PP, Hou ZJ, Li HM, Zhang JX, et al
    Reprogramming M2 macrophages via TLR7/8 agonist-loaded hollow MnO2 nanovehicles to suppress the progression of liver cancer.
    PLoS One. 2026;21:e0358567.
    

    >> Share

    
    
45. GOODMAN AZ, Stauffer WT, Gallay PA
    Divergent effects of semaglutide and CRV431 Co-therapy on liver fibrosis and HCC in MASLD mouse model.
    PLoS One. 2026;21:e0358225.
    

    >> Share

    
    
46. DE SOYZA J, Ellis P, Spittle D, Pye A, et al
    Validation of the Bronchiectasis Severity Index in alpha-1 antitrypsin deficiency.
    PLoS One. 2026;21:e0355956.
    

    >> Share

    
    
47. HAWRO I, Lee SM, Kineman RD, Cordoba-Chacon J, et al
    PPARgamma-dependent and -independent regulation of genes involved in hepatic methionine cycle in fasted or diet-induced obese mice.
    PLoS One. 2026;21:e0358698.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

48. LI Z, Sun C, Wang X, Tian S, et al
    A Vision Transformer- and Radiomics-based Model for Predicting Liver Metastasis-Free Survival in Patients with Rectal Cancer.
    Radiol Imaging Cancer. 2026;8:e250440.
    

    >> Share

    
    

    
    Transplant Proc

49. CELIK F, Aksoy F, Saglam K, Ugras N, et al
    Survival of Hepatocellular Carcinoma After Liver Transplantation: Validation of Malatya Criteria.
    Transplant Proc. 2026 Sep 17:S0041-1345(26)00455.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share